Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Laura Notarfranchi
Observed names:
L. Notarfranchi,
NOTARFRANCHI, LAURA
Institution:
Azienda USL Toscana Nord Ovest
Observed institutions:
University of Parma,
Navarre Institute of Health Research,
Clinica Universidad de Navarra,
Ospedale di Parma,
Centro de Investigación Médica Aplicada,
Azienda USL Toscana Nord Ovest
show all 6
ORCID:
0000-0002-4069-1323
Observed ORCID:
0000-0002-4069-1323
OpenAlex ID:
A5048738889
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties
2017
·
Federica Costa
, Rosanna Vescovini
, et al.
·
Oncotarget
·
35
PDF
Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma
2021
·
Alessandra Romano
, Paola Storti
, et al.
·
Frontiers in Oncology
·
26
PDF
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients
2021
·
Federica Costa
, Rosanna Vescovini
, et al.
·
Frontiers in Immunology
·
23
PDF
Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment
2025
·
Marta Lasa
, Carmen Gonzalez
, et al.
·
Blood
·
21
PDF
Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma
2024
·
Marta Lasa
, Laura Notarfranchi
, et al.
·
Journal of Clinical Oncology
·
20
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response
2022
·
Paola Storti
, Valentina Marchica
, et al.
·
OncoImmunology
·
19
Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results
2021
·
Rita Fazzi
, Iacopo Petrini
, et al.
·
Frontiers in Immunology
·
18
PDF
Ultra-Sensitive Assessment of Measurable Residual Disease (MRD) in Peripheral Blood (PB) of Multiple Myeloma (MM) Patients Using Bloodflow
2022
·
Laura Notarfranchi
, Anastasiia Zherniakova
, et al.
·
Blood
·
17
Hairy cell leukaemia mimicking multiple myeloma
2019
·
Laura Notarfranchi
, Filomena Russo
, et al.
·
The Lancet Oncology
·
14
Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma
2020
·
Martina Manzoni
, Valentina Marchica
, et al.
·
Cancers
·
12
PDF
CD38 expression by plasma cells in extramedullary multiple myeloma
2023
·
Laura Notarfranchi
, Fabrizio Accardi
, et al.
·
Haematologica
·
10
PDF
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis
2018
·
Fabrizio Accardi
, Valentina Papa
, et al.
·
Case Reports in Hematology
·
10
PDF
Minimally Invasive Assessment of Measurable Residual Disease (MRD) in Multiple Myeloma (MM)
2023
·
Carmen Gonzalez
, Marta Lasa
, et al.
·
Blood
·
7
Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma
2023
·
Jessica Burroughs Garcia
, Paola Storti
, et al.
·
Haematologica
·
7
PDF
Mesangiogenic progenitor cells are forced toward the angiogenic fate, in multiple myeloma
2019
·
Simone Pacini
, Marina Montali
, et al.
·
Oncotarget
·
6
PDF
Concomitant Primary Hyperparathyroidism in Patients with Multiple Myeloma: A Possible Link?
2020
·
Laura Notarfranchi
, Valentina Marchica
, et al.
·
Acta Haematologica
·
5
Bone marrow Dikkopf‐1 levels are a new independent risk factor for progression in patients with smouldering myeloma
2017
·
Benedetta Dalla Palma
, Valentina Marchica
, et al.
·
British Journal of Haematology
·
5
PDF
Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients
2025
·
Vincenzo Raimondi
, Paola Storti
, et al.
·
Frontiers in Immunology
·
3
PDF
P-092: Impaired glutamine/glutamate metabolic axis into myeloma microenvironment affects osteoclast formation.
2022
·
Denise Toscani
, Martina Chiu
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
2
Short-Term Risk for Progression in Patients with Smoldering Multiple Myeloma: The Impact of CD56 Expression
2020
·
Laura Notarfranchi
, Rosanna Vescovini
, et al.
·
Blood
·
2
Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients
2020
·
Benedetta Dalla Palma
, Fabrizio Accardi
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
2
Neurofibromatosis type I and multiple myeloma coexistence: A possible link?
2018
·
Fabrizio Accardi
, Valentina Marchica
, et al.
·
Hematology Reports
·
2
PDF
Phase II Study of the Combination of Interleukin-2 with Zoledronic Acid As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma
2016
·
Gabriele Buda
, Rita Fazzi
, et al.
·
Blood
·
2
Advances in the pathophysiology and treatment of anaemia in multiple myeloma
2026
·
Nicola Giuliani
, Benedetta dalla Palma
, et al.
·
Current Opinion in Hematology
·
1
P58 Low Cd38 Expression by Plasma Cells in Extramedullary Disease in Multiple Myeloma Patients
2023
·
L. Notarfranchi
, F. Accardi
, et al.
·
HemaSphere
·
1
Show more works
View as search
Works count:
44
Citation count:
271
H-index:
10
I10-index:
12
Year
Topic
Type